Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS HEALTH CORPORATION : Ex-dividend day for

07/22/2021 EDT

A dividend is removed today from CVS Health Corporation's share.



ę Factset 2021
All news about CVS HEALTH CORPORATION
09/21CVS HEALTH : Aetna and Oui Health aim for significant impact on suicide
PU
09/20Healthcare Shares Fall Amid Concerns About Delta Variant -- Healthcare Roundup
DJ
09/20CVS HEALTH : to Hire 25,000 Staff to Prepare for Expected Flu Incidence Spike, Continued C..
MT
09/20WALGREENS BOOTS ALLIANCE : CVS Health to hire 25,000 ahead of flu season, COVID-19 booster..
RE
09/20CVS HEALTH : to Hire 25,000 Across the U.S. During One-Day Virtual Career Event
PR
09/20THE LATEST : Virus cases down dramatically in West Virginia
AQ
09/17CVS HEALTH : Novo Nordisk Inc. join forces to provide enhanced, personalized support for o..
PU
09/17CVS Health and Novo Nordisk Inc. Join Forces to Provide Enhanced, Personalized Support ..
CI
09/15CVS HEALTH : Caremark launches new efforts to tackle health disparities
PU
09/09CVS HEALTH : responds to latest update on COVID-19 vaccinations and testing
PU
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 284 B - -
Net income 2021 8 454 M - -
Net Debt 2021 48 933 M - -
P/E ratio 2021 13,1x
Yield 2021 2,38%
Capitalization 111 B 111 B -
EV / Sales 2021 0,56x
EV / Sales 2022 0,52x
Nbr of Employees 256 500
Free-Float 75,5%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 83,93 $
Average target price 96,89 $
Spread / Average Target 15,4%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President